Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Figure 1

The nucleic acid conversion time and changes in T cells and lymphocytes in each group. (a) Cumulative negative conversion rate of nucleic acid at each time period in 33 cases. (b) Cumulative negative conversion rate of nucleic acid at each time period in the nonglucocorticoid group (N-CS) and the glucocorticoid group (CS), respectively. The 50% cumulative negative conversion rate (purple dashed line) in the nonglucocorticoid group (green dashed line) and the glucocorticoid group (red dashed line) after admission. (c) Distribution of lymphocytes in the nonglucocorticoid group (N-CS) and the glucocorticoid group (CS) when cumulative conversion reaches 50%. . (d) Distribution of CD3+, CD4+, and CD8+ T cells in the nonglucocorticoid group (N-CS, 20 cases) and the glucocorticoid group (NS, 13 cases) when cumulative conversion reaches 50%. . (e) The distribution of lymphocytes in half of the patients with the nonglucocorticoid group (N-CS, 10 cases) and the glucocorticoid group (NS, 7 cases). ns: not significant. (f) The distribution of CD3+, CD4+, and CD8+ T cells in half of the patients with the nonglucocorticoid group (N-CS, 10 cases) and the glucocorticoid group (CS, 7 cases). ; ns: not significant.

(a)

(b)

(c)

(d)

(e)

(f)